Shares of Precigen Inc. (NASDAQ:PGEN) soared 18% after the biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has granted priority review for its biologics license ...
On February 13, the House Budget Committee, voting 21-16 along party lines (Republicans in favor and Democrats opposed), passed a 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback